Approvals/TGA/XILENTO HCT 16/12.5 candesartan cilexetil and hydrochlorothiazide 16/12.5 mg tablet blister pack

Approved

STANDARD

XILENTO HCT 16/12.5 candesartan cilexetil and hydrochlorothiazide 16/12.5 mg tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 30103c17f3d2325f
Product Name: XILENTO HCT 16/12.5 candesartan cilexetil and hydrochlorothiazide 16/12.5 mg tablet blister pack
Artg Id: 297019
Artg Name: XILENTO HCT 16/12.5 candesartan cilexetil and hydrochlorothiazide 16/12.5 mg tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2019-06-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

30103c17f3d2325f

Type

Standard